Biopharmaceutical Tubing Market Key Players and Forecast by 2031

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Biopharmaceutical Tubing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Plastic, Metal, and Silicone), Application (Pharmaceutical {Single Use Technology, and Others, Medical Devices, Research and Development, and Others), and Geography

  • Report Date : Aug 2025
  • Report Code : TIPRE00008648
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The biopharmaceutical tubing market size is projected to reach US$ 7.64 billion by 2031 from US$ 4.04 billion in 2023. The market is expected to register a CAGR of 8.30% during 2023–2031. Platinum-cured silicone as the material of choice for biopharmaceutical tubing will likely remain a key trend in the market.

 Biopharmaceutical Tubing Market Analysis

Biopharmaceutical tubing is a well-established market. However, because there is an increasing focus on better surgical procedure outcomes and related conditions, it is predicted to grow more quickly.  The main factors driving the market's expansion are the rising number of minimally invasive procedures and the sharply increasing demand for medical devices that use tubing in the area.

According to estimates, the biopharmaceutical tubing market is expected to grow fastest in Asia. The aging population, pharmaceuticals, and the availability of reasonably priced medical-grade plastics will significantly enhance prospects for profit.

Biopharmaceutical Tubing Market Overview

An increase in life expectancy is contributing to the global geriatric population. The World Health Organization (WHO) projects that by 2050, the proportion of adults over 60 worldwide will almost double, from 12% in 2015 to 22%. The World Population Ageing 2017 report from the United Nations states that there were 962 million adults in the world in 2017 who were 60 or older. That figure is projected to rise to approximately 2.1 billion by 2050. Furthermore, the US Census Bureau projects that the population of Americans 65 and older will increase from 46 million in 2016 to over 98 million by 2060, increasing their population share from approximately 15% to approximately 24% during this time. Europe has the most significant proportion of adults over 60 (25%), according to the United Nations World Population Ageing 2017 report. A considerable portion of the population in every region of the world, except Africa, will be 60 or older by 2050 due to the acceleration of global aging. By 2030, 2050, and 2100, respectively, the global geriatric population is projected to amount to US$ 1.4 billion, US$ 2.1 billion, and more than US$ 3.1 billion. The aging population is causing a rise in geriatric illnesses, which in turn is driving up demand for medication delivery systems and diagnostic tools.

Additionally, it is contributing to the rise in the prevalence of urological disorders that need to be catheterized. In addition, doctors are pushing for self-catheterization to lower hospital stays and costs while lowering the risk of infections linked to healthcare (HAI). A critical contributing factor to the rise in chronic illnesses that may necessitate interventions involving ICU admission is aging. The adoption of biopharmaceutical tubing systems is thus driven by the rapid growth in the geriatric population, which is directly correlated with the growing demand for medical devices that incorporate tubing, drug delivery, dialysis, cardiac bypass, peristaltic pump, and sterile filling and dispensing systems.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Biopharmaceutical Tubing Market: Strategic Insights

biopharmaceutical-tubing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Biopharmaceutical Tubing Market Drivers and Opportunities

Rising Demand for Minimally Invasive Procedures Favors Market Growth

A tiny device or an implant is typically inserted into the body through an incision or other anatomical opening during a minimally invasive medical procedure. These procedures have become increasingly popular because they involve small incisions, patients recover more quickly, and patients experience less discomfort. Additionally, these operations are linked to advantages like reduced pain, minimal tissue damage, and less trauma to the muscles, nerves, tissues, and organs.

The need for less invasive procedures has increased due to the rising incidence of cancer, heart disease, and arthritis, all of which need lengthy surgical treatments. Catheters and biopharmaceutical tubing, among other components, are in high demand. Biopharmaceutical tubing systems also help with time-saving procedures and are reasonably priced. For instance, the time needed for the medical or surgical procedure is significantly reduced when catheter tubing is used for cardiac and urine catheterization. Thus, the increasing need for less invasive medical procedures and the emphasis on making these procedures more efficient are significant factors driving the market for biopharmaceutical tubing.

Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries Creates Significant Opportunities in the Market

Chronic disease prevalence is on the rise in developing nations as a result of significant, gradual changes in lifestyle. Moreover, the prevalence of other health conditions, such as occupational disorders, is rising due to the adoption of modern work cultures and infrastructure. Modern facilities cause their occupants to engage in less physical activity, but the intense competition in the market also contributes to increased stress levels. Thus, the need for catheters and biopharmaceutical tubing will rise in these economies as the prevalence of chronic diseases increases and more people seek medical attention. The economies of Brazil, India, Russia, China, and South Africa (BRICS) are some of the fastest-growing in the world. The aging population, changes in customer demand, and increased awareness of healthcare services are all expected to contribute to the projected rapid expansion of the healthcare sectors in these and other developing economies shortly. The biopharmaceutical tubing market is expected to have substantial potential in the upcoming years due to the growth of this industry. The development of the healthcare sector and the biopharmaceutical tubing market is also anticipated to be aided by higher government spending on healthcare facilities and rising consumer purchasing power.

Biopharmaceutical Tubing Market Report Segmentation Analysis

Key segments that contributed to the derivation of the biopharmaceutical tubing market analysis are type and application.

  • Based on type, the biopharmaceutical tubing market is divided into plastic, metal, and silicone. The silicone segment held the most significant market share in 2023.
  • By application, the market is categorized into pharmaceutical {single use technology and others, research and development, medical devices, and others. The pharmaceutical segment held the largest share of the market in 2023.

Biopharmaceutical Tubing Market Share Analysis by Geography

The geographic scope of the biopharmaceutical tubing market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America consists of three countries: the US, Canada, and Mexico. The US held the largest share of the rising demand for medical devices that incorporate tubing. The adoption of advanced medical devices, technological advancements, and a shift toward minimally invasive medical procedures are projected to accelerate the growth of the biopharmaceutical tubing market. Moreover, Market players are adopting organic and inorganic growth strategies for market development. For instance, In November 2019, Saint-Gobain Life Sciences completed construction on its new plant in Largo, Florida, marking another key milestone in its €70 million worldwide expansion initiative, which will see seven production locations built and operational by the end of 2020. The 80,000 SF Largo, FL, facility will become an additional manufacturing site for Saint-Gobain’s C-Flex tubing, molded connections, and assemblies used in fluid management for biopharmaceutical manufacturing. Saint-Gobain will continue to produce C-Flexs tubing and related product lines at its existing facilities in Clearwater, FL; Charny, France; and Bangalore, India.

Similarly, in March 2017, AdvantaPure launched the AdvantaSil brand of silicone tubing and hose. AdvantaSil silicone tubing and hose products are for single-use processes, from the reinforced hose, unreinforced tubing wire reinforced suction hose, and pump grade tubing. The products are designed and tested for the pharmaceutical and biopharmaceutical industries.

Thus, owing to the factors mentioned above, the biopharmaceutical tubing market is anticipated to grow in the coming years in the country

Biopharmaceutical Tubing Market Regional Insights

The regional trends and factors influencing the Biopharmaceutical Tubing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Biopharmaceutical Tubing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

biopharmaceutical-tubing-market-global-geography
  • Get the Regional Specific Data for Biopharmaceutical Tubing Market

Biopharmaceutical Tubing Market Report Scope

Report Attribute Details
Market size in 2023 US$ 4.04 Billion
Market Size by 2031 US$ 7.64 Billion
Global CAGR (2023 - 2031) 8.30%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Plastic
  • Metal
  • Silicone
By Application
  • Pharmaceutical
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • W. L. Gore and Associates, Inc.
  • Saint-Gobain Sekurit
  • Freudenberg Group
  • RAUMEDIC AG
  • TEKNI-PLEX
  • NewAge Industries, Inc.
  • Optinova
  • Zeus Industrial Products, Inc.
  • NORDSON CORPORATION
  • DuPont de Nemours, Inc.

  • Biopharmaceutical Tubing Market Players Density: Understanding Its Impact on Business Dynamics

    The Biopharmaceutical Tubing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Biopharmaceutical Tubing Market are:

    1. W. L. Gore and Associates, Inc.
    2. Saint-Gobain Sekurit
    3. Freudenberg Group
    4. RAUMEDIC AG
    5. TEKNI-PLEX
    6. NewAge Industries, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    biopharmaceutical-tubing-market-cagr

    • Get the Biopharmaceutical Tubing Market top key players overview

    Biopharmaceutical Tubing Market News and Recent Developments

    The biopharmaceutical tubing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the biopharmaceutical tubing market are listed below:

    • DuPont is accelerating its investments for the future of the biopharmaceutical processing industry by expanding its supply capacity of silicone elastomers and tubing and by enlarging its single-use pharma product lines with new thermoplastic elastomer (TPE) tubing (Source: DuPont, Press Release, April 2022)
    • Optinova opened its Optinova Valley Forge plant. The new factory is an investment to significantly increase production capacity for specialty industrial tubing solutions. Optinova Valley Forge can house over 20 extrusion lines at maximum capacity and have 11 extrusion lines up. (Source: Optinova, Press Release, May 2021)

    Biopharmaceutical Tubing Market Report Coverage and Deliverables

    The “Biopharmaceutical Tubing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Biopharmaceutical tubing market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Biopharmaceutical tubing market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Biopharmaceutical tubing market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the biopharmaceutical tubing market
    • Detailed company profiles

    Frequently Asked Questions

    What is the expected CAGR of the biopharmaceutical tubing market?

    The market is expected to register a CAGR of 8.30% during 2023–2031.

    Which are the leading players operating in the biopharmaceutical tubing market?

    W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG

    What are the driving factors impacting the biopharmaceutical tubing market?

    Key factors driving the market are the increasing elderly population worldwide and the rising demand for minimally invasive procedures.

    What are the future trends of the biopharmaceutical tubing market?

    Platinum-cured silicone as the material of choice for biopharmaceutical tubing will likely remain a key trend in the market.

    Which region dominated the biopharmaceutical tubing market in 2023?

    North America dominated the biopharmaceutical tubing market in 2023

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo